comparison gene expression pattern in blood sample of patients with major depressive disorder

Comparison of gene expression pattern in blood sample of depressed patients treated with fluoxetine and cognitive-behavioral therapy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190710044171N1

Enrollment

Registered

2020-09-08

Start date

2020-06-09

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder. Major depressive disorder, single episode, mild

Interventions

Intervention 1: Intervention group: The group receiving 12 sessions of cognitive-behavioral therapy is a group that psychotherapists use to educate people and change their feelings and behaviors throu

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Diagnosis of major depression Range 18-55 years Graduated from middle school Having minimum physical and cognitive abilities to participate in intervention sessions Lack of psychosis and hurting oneself and others Not receiving any other psychological treatment at the same time

Exclusion criteria

Exclusion criteria: Acute psychiatric disorders according to the psychiatrist Having a serious medical condition and limiting Taking intervening drugs

Design outcomes

Primary

Measure	Time frame
Change of gene in trial. Timepoint: evaluation of change in gene after 6 weeks treatment. Method of measurement: gene description.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Ghalehnoei

Mazandaran university of medical sciences

hossein.ghalehnoei58@gmail.com+98 11 3334 9337

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026